Fig 2.

Significant fibrosis (A) and advanced fibrosis (B) according to glucose intolerance. *Significant fibrosis and advanced fibrosis were defined as liver stiffness measurement in magnetic resonance elastography ≥ 2.97 kPa and ≥ 3.62 kPa, respectively. No glucose intolerance was defined as fasting blood sugar (FBS) levels < 100 mg/dl and hemoglobin A1c (HbA1c) < 5.7%. Prediabetes was defined as FBS levels of 100 to 125 mg/dl or hemoglobin A1c (HbA1c) levels of 5.7% to 6.4%. Diabetes mellitus was defined as FBS ≥ 126 mg/dL or hemoglobin A1c (HbA1c) ≥ 6.5% or treatment with anti-diabetic medication.